Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium ... biotechnology company focused on the ...
News
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer ...
- Silicon Valley Tech Boss Snags $13.7M Upper East Side Townhouse - Hoodline
The company says its products are used by large banks, healthcare providers and biotech firms, according to Data Theorem. ... SAN ANTONIO SAN DIEGO ...
- Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the ... - The Manila Times
... San Antonio Breast Cancer Symposium ('SABCS”) today, Thursday, December 11 ... Celcuity is a clinical-stage biotechnology company pursuing development ...
- Intensity Therapeutics, Inc. to Present Two Posters at the 2025 - GuruFocus
... Biotechnology NAS:INTS. Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium. Author's Avatar.
- Pfizer Builds Case for Tukysa as 'New Standard Regimen' in First-Line Metastatic Breast Cancer
Results, announced Wednesday and presented at the 48th San Antonio Breast Cancer Symposium (SABCS), showed the Tukysa-based combo cut the risk of ...